CT-P13 (Infliximab) Subcutaneous Administration by Pre-filled Syringe and Auto-injector in Healthy Subjects

Completed · Phase 1

Conditions studied: Health, Subjective

In brief

This study compares two administration methods of CT-P13. Half of participants will receive CT-P13 by pre-filled syringe while the other half will receive CT-P13 by auto-injector.

Key facts

Study ID

NCT03446976

Run by

Celltrion

People needed

218

Starts

2018-02-21

Expected to finish

2018-07-26

Last updated by the study team

2019-07-26

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male and female subject
• Subject voluntarily agrees to participate in this study

You may not qualify if…

• Subject with medical history and/or condition
• Female who is pregnant or breastfeeding, or childbearing potential.

Where it is running

• PPD Development, LP — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.